Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
Clinical trial NCT01920711 · COMPLETED
Trial details
- NCT number
- NCT01920711
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-18
- Primary completion
- 2019-06-07
- Enrollment
- 4822
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.